Acuitive Technologies earns FDA clearance for new bone void filler

Acuitive Technologies earned FDA clearance for the Citrepore bioactive bone filler, the company said Nov. 12.

Advertisement

Four things to know:

1. Citrate is designed for orthopedic surgery and is made with the company’s patented Citregen biomaterial.

2. The implant is reabsorbed and replaced by the patient’s bone and lets Citrepore guide healing metabolically.

3. Citrepore has more than 80% porosity and is osteoconductive and bioactive.

4. The implant is available in a variety of performed shapes and sizes and can be cut or morselized.

Advertisement

Next Up in Biologics

  • Regenerative medicine company Auragens has opened an orthobiologics division.  Orthopedic surgeon Abdiel Ortiz, MD, will lead the new division, which…

  • So far this year, medtech companies and academic institutions are making key strides in spine biologics. From new product launches…

Advertisement

Comments are closed.